home / stock / huma / huma articles

HUMA Articles, Humacyte Inc. - From 03/01/24

Stock Information
Company Name: Humacyte Inc.
Stock Symbol: HUMA
Market: NASDAQ
Website: humacyte.com
Menu
HUMA HUMA Quote HUMA Short HUMA News HUMA Articles HUMA Message Board
Get HUMA Alerts

News, Short Squeeze, Breakout and More Instantly...
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference | Benzinga

DURHAM, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing univer...
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than-expected thir...

Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session | Benzinga

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday. Shares of Hewlett Packard Enterprise...

Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock | Benzinga

DURHAM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing univers...
Why Is Clinical-Stage Biotechnology Platform Company Humacyte Stock Gaining Friday? | Benzinga

Humacyte, Inc. (NASDAQ:HUMA) shares are trading higher on Friday. The company announced that the U.S. FDA has accepted and granted Priori...

Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks traded mostly lower, with the Nasdaq Composite falling over 200 points on Wednesday. Shares of The Boeing Company (NYSE: BA) rose duri...

Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference | Benzinga

DURHAM, N.C., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing univers...
Humacyte to Present at the Cantor Global Healthcare Conference | Benzinga

DURHAM, N.C., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing unive...

Humacyte to Host In-Person KOL Event at the New York EDITION on September 20, 2023 | Benzinga

DURHAM, N.C., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing univer...

Regenerative Medicine Firm Humacyte's Bioengineered Tissue Shows Promise In Trauma Injuries | Benzinga

Humacyte Inc (NASDAQ: HUMA) released topline results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repa...
Previous 10 Next 10